The Gold Standard is a workplace- based program that focuses on lowering the risk of cancer.
Visit Website

The Life Sciences Consortium (LSC) brings together oncology companies to accelerate discovery and development of new therapies for all cancer patients. Visit Website

Christopher A. Viehbacher

Chairman, CEO Roundtable on Cancer

Chris Viehbacher, born March 26, 1960, holds German and Canadian nationalities. He is a graduate of the Queens University (Ontario – Canada) and a certified public accountant.

After beginning his career at PriceWaterhouseCoopers, between 1988-2008 he acquired broad international experience in Europe, in the United States and in Canada with the GlaxoSmithKline (GSK) Company. In his last position, Chris Viehbacher was President, Pharmaceutical Operations North America, a member of the board and Co-Chairman of the Portfolio Management Board.

Chris Viehbacher is Chairman of PhRMA in the United States since December 2010 and was elected Chair of the CEO Roundtable on Cancer in February 2011.

Chris Viehbacher is married with three children. He speaks French, English and German: he lived in France for nine years when he was General Manager of GSK France. He was made a knight of the French Legion of Honor in 2003.